Bank of Montreal
PGNX

Bank of Montreal’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bank of Montreal’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-419
Closed -$1K – 4948
2020
Q1 		$1K Sell
419
-13,505
-97% -$58.2K ﹤0.01% 4034
2019
Q4 		$71K Buy
13,924
+4,023
+41% +$21.3K ﹤0.01% 3663
2019
Q3 		$50K Sell
9,901
-2,385
-19% -$11.9K ﹤0.01% 3627
2019
Q2 		$76K Buy
12,286
+10,002
+438% +$48.2K ﹤0.01% 3496
2019
Q1 		$11K Buy
2,284
+1,088
+91% +$4.92K ﹤0.01% 3861
2018
Q4 		$5K Buy
1,196
+613
+105% +$3.12K ﹤0.01% 4130
2018
Q3 		$4K Buy
583
+56
+11% +$430 ﹤0.01% 4198
2018
Q2 		$4K Buy
+527
New +$4.02K ﹤0.01% 4212
2017
Q2 		– Sell
-1,481
Closed -$14K – 4356
2017
Q1 		$14K Buy
+1,481
New +$14.8K ﹤0.01% 3471
2016
Q1 		– Sell
-17,316
Closed -$106K – 4490
2015
Q4 		$106K Buy
17,316
+4,859
+39% +$31.9K ﹤0.01% 2753
2015
Q3 		$71K Sell
12,457
-3,030
-20% -$23.3K ﹤0.01% 2778
2015
Q2 		$116K Buy
15,487
+6,100
+65% +$36.9K ﹤0.01% 2673
2015
Q1 		$56K Buy
+9,387
New +$59.1K ﹤0.01% 2876
2014
Q3 		– Sell
-1,720
Closed -$7K – 4587
2014
Q2 		$7K Buy
+1,720
New +$6.57K ﹤0.01% 4035

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Bank of Montreal's PGNX Position: Q2 2020 in Review

Bank of Montreal sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 419 shares — an estimated $1K sold.

Bank of Montreal first reported a position in PGNX in Q2 2014 and held it in 14 quarters. The position peaked at $116K in Q2 2015. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Bank of Montreal reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Bank of Montreal sold 419 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $1K.
  • Bank of Montreal first reported a position in Progenics Pharmaceuticals Inc in Q2 2014 and held it in 14 quarters.
  • Bank of Montreal's Progenics Pharmaceuticals Inc position peaked at $116K in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.